USD 20.72
(4.17%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -6.23 Million | -3.31 Million | 2.09 Million | -2.42 Million | 48.79 Million | 34.32 Million |
Net Income | 225.99 Million | -4.1 Million | 211.78 Million | 113.21 Million | 209.71 Million | -95.73 Thousand |
Depreciation & Amortization | - | - | - | - | 38.4 Million | 24.86 Million |
Deferred income taxes | - | - | - | - | -48.21 Million | - |
Stock-based compensation | 200.89 Thousand | 182.63 Thousand | 172.39 Thousand | 168.46 Thousand | 9.46 Million | 13.06 Million |
Change in working capital | - | - | - | - | 340.88 Thousand | -869.53 Thousand |
Other non-cash items | -232.43 Million | 601.49 Thousand | -209.85 Million | -115.8 Million | -160.91 Million | 34.41 Million |
Investing Cash Flow | 44.27 Million | 87.23 Million | 36.16 Million | 21.18 Million | -572.4 Million | -590.18 Million |
Investments in PPE | - | - | - | - | -312.14 Million | -402.84 Million |
Acquisitions | - | 87.23 Million | 21.67 Million | 21.18 Million | -177.04 Million | -40.15 Million |
Investment purchases | -3.38 Million | - | - | - | -330.7 Million | -62.29 Million |
Sales/Maturities of investments | - | - | - | - | 125.53 Million | 28.78 Million |
Other Investing Activities | 47.65 Million | 32.18 Million | 14.48 Million | 6.46 Million | 121.95 Million | -113.65 Million |
Financing Cash Flow | -48.03 Million | -54.57 Million | -22.08 Million | -14.53 Million | 63.71 Million | 296.94 Million |
Debt repayment | - | - | - | - | -523.39 Million | -474.72 Million |
Dividends payments | - | - | - | - | -11.4 Million | -10.01 Million |
Common Stock Repurchased | -47.83 Million | -54.32 Million | -21.89 Million | - | -75.42 Million | -44.71 Million |
Common Stock Issuance | -203 Thousand | -247 Thousand | -194 Thousand | -317 Thousand | -54.24 Million | -64.02 Million |
Other Financing Activities | - | - | - | -14.21 Million | 728.19 Million | 890.42 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 340.88 Thousand | -869.53 Thousand |
Cash at beginning of period | 23.36 Million | 7.2 Million | 855 Thousand | 1.24 Million | 256.93 Million | 346.23 Million |
Cash at end of period | 12.31 Million | 23.36 Million | 7.2 Million | 855 Thousand | 1.24 Million | 256.93 Million |
Capital Expenditure | - | - | - | - | -312.14 Million | -402.84 Million |
Effect of forex changes on cash | -1.05 Million | -6.67 Million | -115 Thousand | 39 Thousand | -3.29 Million | -8.41 Million |
Net cash flow / Change in cash | -11.04 Million | 16.16 Million | 6.34 Million | -388 Thousand | -255.68 Million | -89.3 Million |
Free Cash Flow | -6.23 Million | -3.31 Million | 2.09 Million | -2.42 Million | -263.34 Million | -368.52 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -71.05 Million | 106.6 Million | 140.11 Million | 225.99 Million | 55.28 Million | 96.24 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 1.36 Million | -4.12 Million | 200.89 Thousand | 1.25 Million | 1.36 Million |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 81.87 Million | -107.96 Million | -127.69 Million | -232.43 Million | -56.54 Million | -92.82 Million |
Investing Cash Flow | 1.24 Million | - | -1.29 Million | 44.27 Million | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -1.29 Million | -3.38 Million | - | - |
Sales/Maturities of investments | 1.24 Million | - | - | - | - | - |
Other Investing Activities | - | - | - | 47.65 Million | - | - |
Financing Cash Flow | -16.08 Million | - | -8.21 Million | -48.03 Million | - | -10.14 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -16.08 Million | - | -8.29 Million | -47.83 Million | - | -10.06 Million |
Common Stock Issuance | - | - | - | -203 Thousand | - | - |
Other Financing Activities | - | - | 80.8 Thousand | - | - | -80.56 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 4.57 Million | - | 2.06 Million | 23.36 Million | - | 8.71 Million |
Cash at end of period | 514.16 Thousand | - | 4.57 Million | 12.31 Million | - | 2.06 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | -403.89 Thousand | -1.05 Million | - | - |
Net cash flow / Change in cash | -4.05 Million | - | 2.51 Million | -11.04 Million | - | -6.65 Million |
Free Cash Flow | 10.82 Million | - | 12.42 Million | -6.23 Million | - | 3.42 Million |
PEA
VET
SMFX
ECN
ABS
6390